Skip to main content

Advertisement

SpringerLink
Log in

Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Niu JY, Tian T, Zhu HY, Liang JH, Wu W, Cao L, Lu RN, Wang L, Li JY, Xu W (2018) Hyperfibrinogenemia is a poor prognostic factor in diffuse large B cell lymphoma. Ann Hematol 97:1841–1849

    Article  CAS  Google Scholar 

  2. Ridker PM, Howard CP, Walter V et al (2012) Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation 126:2739–2748

    Article  CAS  Google Scholar 

  3. Taniguchi K, Karin M (2014) IL-6 and related cytokines as the critical lynchpins between inflammation and cancer. Semin Immunol 26:54–74

    Article  CAS  Google Scholar 

  4. Pardanani A, Finke C, Lasho TL et al (2012) IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes. Leukemia 26:693–699

    Article  CAS  Google Scholar 

  5. Sahni A, Simpson-Hanidaris PJ, Sahni SK et al (2008) Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor-2 (FGF-2). J Thromb Haemost 6:176–183

    Article  CAS  Google Scholar 

  6. Sahni A, Khorana AA, Baggs RB et al (2006) FGF-2 binding to fibrinogen is required for augmented angiogenesis. Blood 107:126–131

    Article  CAS  Google Scholar 

  7. Sahni A, Francis CW (2000) Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 96:3772–3778

    Article  CAS  Google Scholar 

  8. Witsch E, Sela M, Yarden Y (2010) Roles for growth factors in cancer progression. Physiology (Bethesda) 25:85–101

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Yokohama Municipal Citizen’s Hospital, 56 Okazawa-cho, Hodogaya-ku, Yokohama, 240-8555, Japan

    Shinji Ogura, Shoichiro Yonei, Tomohiko Tanigawa, Masahiro Akimoto, Aki Sakurai, Yuriko Fujita, Chisako Ito, Yoshinobu Aisa & Tomonori Nakazato

Authors
  1. Shinji Ogura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shoichiro Yonei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomohiko Tanigawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Masahiro Akimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aki Sakurai
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuriko Fujita
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Chisako Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yoshinobu Aisa
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Tomonori Nakazato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomonori Nakazato.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Statement of informed consent

Informed consent was obtained from the patients. The study was approved by the Ethics Committee of Yokohama Municipal Citizen’s Hospital.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ogura, S., Yonei, S., Tanigawa, T. et al. Prognostic significance of hyperfibrinogenemia in patients with lower-risk myelodysplastic syndromes. Ann Hematol 99, 189–191 (2020). https://doi.org/10.1007/s00277-019-03863-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-019-03863-z

Search

Navigation